# Albumin for Patients With Acute Large Vessel Occlusive Stroke Undergoing Endovascular Reperfusion Therapy

Study · id `cardio:ct-nct06538844` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06538844](<https://clinicaltrials.gov/study/NCT06538844>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06538844

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 134 participants.

## Technical summary

Registry record NCT06538844. Randomized; double masking; primary purpose treatment. Start 2024-08-10 (actual); primary completion 2024-12-20 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 134 participants (enrolled count; ClinicalTrials.gov record NCT06538844, source copy `cardio:ctgov-nct06538844-2025-04-02`, retrieved 2026-10-26)
- Started: 2024-08-10 (actual) (ClinicalTrials.gov record NCT06538844, source copy `cardio:ctgov-nct06538844-2025-04-02`, retrieved 2026-10-26)
- Primary completion: 2024-12-20 (actual) (ClinicalTrials.gov record NCT06538844, source copy `cardio:ctgov-nct06538844-2025-04-02`, retrieved 2026-10-26)
- Completion: 2025-03-15 (actual) (ClinicalTrials.gov record NCT06538844, source copy `cardio:ctgov-nct06538844-2025-04-02`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT06538844, source copy `cardio:ctgov-nct06538844-2025-04-02`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06538844-2025-04-02`, retrieved 2026-10-26)

## The registry's words

- Brief title: Albumin for Patients With Acute Large Vessel Occlusive Stroke Undergoing Endovascular Reperfusion Therapy
- Condition: Acute Ischemic Stroke
- Intervention (Drug): Intravenous infusion of human albumin
- Intervention (Drug): Saline
- Lead sponsor: Capital Medical University
- Lead sponsor class: OTHER
- Collaborator: Xuanwu Hospital, Beijing
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Capital Medical University (`cardio:org-capital-medical-university`)
- Registry lists this organization as a collaborator: Xuanwu Hospital, Beijing (`cardio:org-xuanwu-hospital-beijing`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Efficacy and safety of albumin combined with endovascular therapy in the treatment of patients with acute ischemic stroke: a randomized clinical trial (`cardio:pubmed-42010254`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: ef9c6ae5cb6d7dfb7830889aeb63bc1d22f8791d6998edec26441e40fee77a26
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
